中国生物制药（01177）今日盘中大涨6.07%，引发市场关注。与此同时，多只医药股也呈现上涨态势，百济神州（06160）涨6.68%，三生制药（01530）涨6.00%，信达生物（01801）涨5.05%，科伦博泰生物-B（06990）涨3.10%，先声药业（02096）涨2.91%。
此轮医药股走强与即将到来的流感季密切相关。国家疾控局在新闻发布会上预计，今年秋冬季我国流感疫情高峰可能出现在12月中下旬和1月初。中国疾病预防控制中心最新发布的流感监测周报显示，南方省份流感活动上升，北方大部分省份也呈上升趋势。全国共报告347起流感样病例暴发疫情，其中大部分为A(H3N2)型流感。目前，我国已进入呼吸道传染病高发季节，疫情总体呈上升趋势，流感活动正逐步进入快速上升阶段。
分析人士认为，随着流感季的来临，相关药品需求可能会显著增加，这将直接利好包括中国生物制药在内的医药企业。此外，中金公司发布研报指出，中国创新药企出海趋势明确，药品先行，器械等领域也具备潜力。在创新药发展及投融资环境改善的背景下，医药行业正迎来新一轮发展机遇。投资者对医药板块的前景持乐观态度，推动相关个股股价上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.